Omnicell, Inc.

Healthcare

NASDAQ:OMCL · NASDAQ Global Select

Market Cap $1.74B Beta 0.96 P/E (TTM) 83.9

$37.83 +0.03%

+$0.01 today

52W Low $26.85High $55.00

Vol 0.61M · Avg 0.56M

EPS (TTM)$0.45

Medical - Healthcare Information Services

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+29.33%

Period High

$51.39

Period Low

$26.88

Latest

$37.83

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

10x Genomics, Inc.

NASDAQ:TXG

$3.66B

Progyny, Inc.

NASDAQ:PGNY

$2.09B

Astrana Health, Inc.

NASDAQ:ASTH

$1.91B

UFP Technologies, Inc.

NASDAQ:UFPT

$1.82B

Teladoc Health, Inc.

NYSE:TDOC

$1.32B

Schrödinger, Inc.

NASDAQ:SDGR

$1.08B

Omada Health

NASDAQ:OMDA

$1.02B

GoodRx Holdings, Inc.

NASDAQ:GDRX

$918.57M

SS Innovations International, Inc.

NASDAQ:SSII

$672.44M

Phreesia, Inc.

NYSE:PHR

$560.02M

What is the latest OMCL filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does OMCL have?

Intrinsic Alpha currently shows 20 recent filings for OMCL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.